Download LITEVAN 2017 Speaker Objectives

 Request for Contact Hours
2017
Demographic Information
Educational Event: LITEVAN Annual Educational Meeting, April 20-21, 2017
Title of Event:
A Bright Future for Vascular Access
Sessions:
12 session consisting of 12 hours of continuing education
Planning Committee: The planning committee consists of the LITEVAN Board of Directors:
Anne Marie Parry, Dawn Thomas, Dave Ingram, Gloria Aquillo, and Peggy Pearl
Faculty/Presenter/Author Name
Joan Hebden
Credentials
RN, MS, CIC
Gregory Schears
MD
Nancy Moreau
BSN, CRNI, CPUI, VA-BC
Cheryl Gordon
CRNI
Michelle (Chellie) DeVries
MPH, CIC
MD
Vineet Chopra
RN
Eddie Korycka
RPh
Dean Parry
Jim Lacy
BSN, RN, VA-BC
Laura Fisk
N/A
Presenter
Joan Hebden
Gregory
Schears
Nancy Moreau
Course Title
Objectives
Chlorhexidine Gluconate
for the Prevention of
Central Line-Associated
Bloodstream Infections
1. Define the mechanism of action of
chlorhexidine gluconate (CHG)
2. Understand the two modes of
bacterial pathogenesis into the
bloodstream from intravascular
devices
3. Define the uses of CHG to prevent
central line-associated bloodstream
infections (CLABSI)
4. State the current CDC
recommendations for the use of CHG
to prevent CLABSI
1. Describe how NIR imaging systems
can be used as a screening tool for
vascular pre-assessment.
2. Assess vasculature with NIR
identifying valves, bifurcations and
tortuosities.
3. Distinguish good vs. poor vascular
access targets.
1. Define and describe midlines and
their advantages and benefits.
2. Describe indications and usage
specific to midlines versus
PICCS/CVADS.
• Discuss challenges associated with
central venous access in ICU
Placing PIV Catheters
‘Under the Light’ Using
NIR Technology
Midline
Indications and Usage
Cheryl Gordon Vascular Access
Assessment in the ICU
Length
1 Hour
1 Hour
1 Hour
1 Hour
• Describe an Algorithm for Catheter
Selection
• Compare Risks and Complications
for different central venous catheters
Chellie
DeVries
Peripheral IVs: Think
Big, Look Small ( the
impact PIVs have with
• Review data surrounding risks
associated with Peripheral IVs (PIVs)
1 Hour
the Affordable Care Act,
CLABSI rates, and Cost)
Dean Parry
Biosimilars
Vineet Chopra
Are PICCs the CVC of
the Future?
Eddie Korycka You CAN Get There
From Here; Identify Your
Path to Optimizing Your
Vascular Access Program
Nancy Moreau CLABSI-What Are We
Missing?
• Discuss how care and maintenance
of PIVs relates to the changing
healthcare landscape
• Identify strategies to lessen risks
associated with PIV complications and
sequelae
Understand how the FDA had defined 1 Hour
Bioequivalence
Discuss the potential impact of
bioequivalent products on the
pharmaceutical market
Review State and Nation Laws
concerning Bioequivalent products.
1. Discuss the evidence available
1 Hour
comparing PICCs to other central
venous catheters.
2. Review data regarding current PICC
practices from the Michigan Hospital
Medicine Safety Study.
3. Describe how the Michigan
Appropriateness Guide to
Intravascular Catheters (MAGIC) may
inform the selection of an appropriate
vascular access device.
1. Explore individual and
1 Hour
organizational approaches to vascular
access educational needs.
2. Identify current standards, best
practices and regulatory bodies that
should drive our educational approach
and clinical performance.
3. Develop a “Go Forward” plan for
improving practice and helping your
organizations optimize their vascular
access programs.
1 Hour
1. Describe purpose of any infection
prevention process in effectively
reducing infections and risk to patients
in exploring some of the possibilities
for “What is Missing.”
Dean Parry
Opioid Crisis in PA and
Across the Country
Jim Lacy
Vessel Health and
Preservation
Laura Fisk
I’m Just a Mom!
2. Evaluate common breaks in aseptic
technique for needleless connector
access along with published evidence
of compliance, levels of intraluminal
contamination, and disinfection
practices.
3. Outline eight recommendations and
levels of evidence for improving
disinfection with needleless
connectors.
Understand the impact of the Opioid
Crisis in Pennsylvania and across the
country
Discuss current regulatory and
legislative changes implemented to
combat the opioid crisis
Discuss the role of health care
providers in dealing with the Opioid
Crisis
Gain Perspective on the historical and
current use of opioids
1. Describe the use of the UK
Vessel Health and Preservation
Framework for appropriate
device selection
2. List 3 key principles of
vascular access
3. Recognize the risks associated
with vascular access



1 Hour
1 hour
1 hour
Become familiar with a
parent’s story of a child with a
lifelong disease
Recognize the positive and
negative experiences of various
central lines in a child
Identify ways to improve
education and communication
between caregivers and nursing
staff
Biography of Each Presenter
Faculty/Presenter/Author
Name
Joan Hebden
Gregory Schears
Joan Hebden RN, MS, CIC received her baccalaureate and
master’s degrees from the University of Maryland School of
Nursing. Her clinical background includes general medicine,
oncology and cardiothoracic intensive care. Currently, she is an
independent infection prevention consultant. Previously, she was
employed by Wolters Kluwer Health as a clinical program
manager for the company’s surveillance application and served as
the Director of Infection Prevention and Control for 28 years at the
University of Maryland Medical Center in Baltimore, Maryland.
An accomplished practitioner, Ms. Hebden has presented at
national epidemiology conferences, participated in research
regarding the transmission of multi-drug resistant bacteria,
contributed chapters on infection control to nursing resource texts,
and published in medical and infection control journals. She is
certified in infection control through the Certification Board of
Infection Control and Epidemiology, is an active member of the
Society for Healthcare Epidemiologists of America and the
Association for Professionals in Infection Control and serves as a
section editor and reviewer for the American Journal of Infection
Control.
Dr. Schears is a pediatric Intensivist and anesthesiologist with a
long standing interest in reducing patient complications and
improving our approach to vascular access. He did his pediatric
residency at St. Louis Children's Hospital, his anesthesia
residency, pediatric anesthesia fellowship and pediatric critical
care fellowship at John's Hopkins hospital. He worked at the
Children's Hospital of Philadelphia for 5 years and was recruited
to the Mayo Clinic in 2001 to head the ECMO service. There he
is the physician liaison to the nurse led PICC team, Medical
Director of the ECMO Service and Co-Director of the Congenital
Heart Unit. He is on the editorial board for JAVA and serves on
the AVA Board of Directors as Treasurer and recently chaired
AVA’s strategic planning task force. He is very active with
product development to help reduce vascular access complications
Nancy Moreau
Cheryl Gordon
Chellie DeVries
and has given hundreds of presentations locally, regionally,
nationally and internationally.
Nancy Moureau is an internationally recognized speaker and
expert in the field of peripherally inserted central catheters and
vascular access practice. A nurse for more than 30 years Nancy
continues her clinical work as staff member on the PICC/IV team
at Greenville Memorial Hospital in Greenville, SC. As the owner
and CEO of PICC Excellence, Nancy creates online educational
programs and works with companies to provide education to
clinicians. Nancy is constantly involved with research and
literature analysis, now working in conjunction with Griffith
University and the AVATAR group Alliance for Vascular Access
Teaching and Research as an adjunct associate professor and a
doctoral candidate. Nancy takes on many projects and most
recently chaired the International Consensus Forum for the World
Congress of Vascular Access (WoCoVA) to establish Standard
Minimal Education Requirements for Central Venous Access
Devices. Nancy has established the only registered PICC
Certification process, Certified PICC Ultrasound Inserter, where
those who meet and maintain qualifications gain the credentials
CPUI. She is happy to act as a resource and is available by email
on your handouts or through the website www.piccexcellence.com
Cheryl has been a nurse for 20 years and has spent the last 14
years in the Vascular Access Specialty. She obtained her Certified
Registered Nurse Infusion from INS in 2005 and received her
Vascular Access- Board Certification from the Association of
Vascular Access in 2010. Her background is in Critical Care
where she worked in both Trauma ICU and Surgical ICU.
Currently, she is a Clinical Specialist for Bard Access Systems and
in that role provides on-site education for PICC line placement,
new PICC technologies, Ultrasound Guidance and Midline
insertion across a 7 state region. She has been a speaker for local
and regional nursing conferences on topics including Ultrasound
Guided PIV insertions, Midlines, PICCs, and CLABSI reduction
strategies. She most recently presented internationally on PICC
practices and strategies.
Chellie has over 20 years of experience in infections control and
hospital epidemiology spanning university, federal and community
healthcare systems. Her background is hospital and molecular
epidemiology, and her passion is raising awareness around PIVs.
Chellie has traveled throughout the country speaking to local,
regional and national AVA, INS, APIC and AACN chapters, and
Vineet Chopra
last year brought the message to Saudi Arabia, Kuwait and Kenya.
Chellie was a reviewer from the 2016 INS Standards and recently
authored the chapter on Intravascular Device Associated Infections
for the International Federation of Infection Control Text.
Dr. Chopra is an Asst Prof of Medicine and Research Scientist at
the University of Michigan School of Medicine and the Ann Arbor
VA Medical Center.
A career hospitalist, Dr. Chopra’s research is dedicated to
improving the safety of hospitalized patients through prevention of
hospital-acquired complications. His work focuses on identifying
and preventing complications such as infection and thrombosis
associated with peripherally inserted central catheters. Dr. Chopra
is funded by a Career Development Award from the Agency of
Healthcare Research and Quality and has received grant support
from the National Institute of Aging, the Blue Cross/Blue Shield
Foundation of Michigan and the American Heart Association.
Eddie Korycka
Dean Parry
He is the recipient of numerous research awards including the
2016 Jerome W. Conn Award for Outstanding Research by Junior
Faculty, 2016 Society of Hospital Medicine Excellence in
Research Award, 2014 McDevitt Award for Research Excellence,
and the 2014 Society of Hospital Medicine Young Investigator
Award. He has published over 100 peer-reviewed papers and is
Associate Editor at the American Journal of Medicine and the
Journal of Hospital Medicine. Dr. Chopra is a voting member of
the Center for Disease Control’s Healthcare Infection Control
Practice Advisory Committee (HICPAC).
Eddie has been a nurse since 1989. He has held positions in the
emergency department, as a manager in med/surgery and as a staff
nurse and manager in home infusion. Eddie owned his own
infusion consulting company for over 10 years. He has been an
active member of INS and AVA. He is currently the Clinical
Education Director at Centurion Medical Products. Having
practiced the specialty of infusion therapy and vascular access in
many settings, he looks forward to sharing his expertise and
gaining knowledge from his colleagues wherever he speaks.
Mr. Parry, RPh graduated from Philadelphia College of Pharmacy
and Science in 1981 with a BS in Pharmacy. After graduation he
worked as a pharmacist at Geisinger Medical Center, in Danville,
PA. In January 1985, he accepted a position as Chief Pharmacist
at Macha Mission Hospital in Choma, Zambia, Africa. Mr. Parry
Jim Lacy
Laura Przybysz
was deeply involved in the leadership of the Churches Medical
Association of Zambia and also in the area of research related to
the treatment of malaria. He has co-authored several research
articles related to the treatment of malaria. On his return the
United States in 1995, he again accepted a position at Geisinger
Medical Center and has been actively involved in various areas
including health care redesign projects in the late 1990s and in the
development of various pharmaceutical care programs for the
organization. For 15 years Mr. Parry was responsible for
ambulatory and acute care clinical pharmacy programs throughout
the health system. During that time he worked closely with health
system leadership in the development of processes and guidelines
for appropriate utilization of medications. In his current role as
AVP, Clinical Informatics, we is responsible for bridging the
clinical needs of the organization with the electronic health record,
monitoring changes made for impact on outcomes and utilization
for both pharmacy and supply chain.
Jim Lacy has over 30 years of experience in nursing with a focus
on adult, pediatric and neonatal critical care, home infusion
therapy, infusion nursing, and vascular access. Over the last 20
years Jim has worked in the medical device industry as a Clinical
Marketing Manager, Clinical Director and consultant with focus
on management and creation of education and training programs,
development of clinical educators and trainers, new product
design, research, marketing and clinical customer support.
Jim has presented at both sponsored and invited educational
offerings throughout the United States and internationally. He has
published original articles related to HIV disease, infusion therapy,
vascular access, and vascular access program development. He
was the recipient of the 2011 Suzanne LaVere Herbst Award for
Excellence in Vascular Access, awarded by AVA for lifetime
contributions to the art and science of vascular access.
He has served on the Board of Directors of the Association for
Vascular Access (AVA) and served as the 2013-2014 President of
the Association and is a former Trustee of the Oley Foundation.
Laura Przybysz, mom to a five year old named Nolan. Nolan has
mitochondrial disease and is TPN dependent. After spending the
past five years entrenched in the medical world, I have recently
started pursuing an RN at CCAC.